Biopharmaceutical Manufacturing, Upstream, Downstream processing news

Headlines

What are the benefits of oral delivery of insulin and how can algae support candidate therapeutic proteins?

These are some of the questions we will be asking leading experts next week.

Lonza secures deal with ALSA Ventures to support its portfolio of biotechs

This week saw Swiss CDMO, Lonza, announce a framework collaboration agreement with ALSA Ventures, a London based European biotech investment firm.

© GettyImages/Simon Carter Peter Crowther

Bora Pharmaceuticals acquires CDMO assets from Eden Biologics

Taiwan based CDMO, Bora Pharmaceuticals, says the acquisition of CDMO assets from local player, Eden Biologics, will help it build a presence in large-molecule contract drug development and manufacturing.

(FatCamera/iStock via Getty Images Plus)

AstraZeneca metastatic breast cancer treatment secures FDA approval

The US agency has approved Enhertu for patients diagnosed with HER2-positive metastatic breast cancer previously treated with an anti-HER2-based regimen.

The US has opportunity to bring new efficiencies to advanced biologics manufacturing

The US will play a key role in the development of advanced manufacturing technologies, predicts a report commissioned by CPhI North America ahead of the 2022 show.